Stockscreener 앱 받기
2.40
1.70%
0.05
시간 외 거래:
2.38
-0.02
-0.83%
전일 마감가:
$2.35
열려 있는:
$2.45
하루 거래량:
506.89K
Relative Volume:
2.07
시가총액:
$135.65M
수익:
$26.03M
순이익/손실:
$-17.12M
주가수익비율:
-2.4092
EPS:
-0.9962
순현금흐름:
$-24.53M
1주 성능:
+9.13%
1개월 성능:
-5.16%
6개월 성능:
-15.55%
1년 성능:
+216.56%
1일 변동 폭
$2.385
$2.7199
1주일 범위
$2.19
$2.7199
52주 변동 폭
$0.73
$3.82
코넥트 바이오파마 Stock (CNTB) Company Profile
명칭
Connect Biopharma Holdings Ltd
전화
858-727-1040
주소
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.40 | 132.83M | 26.03M | -17.12M | -24.53M | -0.9962 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
코넥트 바이오파마 Stock (CNTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | Lake Street | Buy |
| 2025-10-31 | 개시 | BTIG Research | Buy |
| 2025-06-12 | 개시 | H.C. Wainwright | Buy |
| 2024-03-04 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | Jefferies | Buy |
| 2021-04-13 | 개시 | Piper Sandler | Overweight |
| 2021-04-13 | 개시 | SVB Leerink | Outperform |
모두보기
코넥트 바이오파마 주식(CNTB)의 최신 뉴스
This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
CNTB Stock Price, Quote & Chart | CONNECT BIOPHARMA HOLDINGS L (NASDAQ:CNTB) - ChartMill
Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026 - inkl
Cantor Fitzgerald initiates Connect Biopharma stock with overweight rating - Investing.com
Cantor Fitzgerald initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com South Africa
Connect Biopharma Growth Plans Raise Financial Discipline Focus - Kalkine Media
Here's Why Connect Biopharma Holdings (NASDAQ:CNTB) Must Use Its Cash Wisely - simplywall.st
Why Is Connect Biopharma Holdings Limited (CNTB) Stock Down Today? - Meyka
Wei Zheng holds 6.2% of Connect Biopharma (CNTB) after March offering - Stock Titan
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Could Be Quite Risky - Yahoo Finance
Connect Biopharma Holdings LtdProposed Resale Of Up To 6.1 Million Ordinary Shares Of Connect BiopharmaSEC Filing - TradingView
Connect Biopharma (CNTB) files resale registration for 6.13M shares - Stock Titan
Connect Biopharma | F-3: Registration statement for specified transactions by certain foreign private issuers - Moomoo
Connect Biopharma : Corporate PresentationMay 2026 (3b1153) - marketscreener.com
BTIG Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Connect Biopharma Holdings Ltd 2026 Q1 Financial Report: Earnings, Cash Flow & Company Overview - Minichart
Connect Biopharma 4Q Loss/Shr 34c >CNTB - Moomoo
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - The Manila Times
Connect Biopharma Holdings Releases Q1 2026 Financial Results - AlphaStreet
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Connect Biopharma Holdings Ltd 1Q 2026: Revenue $169K, EPS ($0.34) — 10-Q Summary - TradingView
Connect Biopharma (NASDAQ: CNTB) boosts R&D and cash with Q1 2026 loss - Stock Titan
Connect Biopharma (NASDAQ: CNTB) widens Q1 loss as rademikibart trials advance - Stock Titan
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Sheboygan Press
BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Northland Securities Weighs in on CNTB Q1 Earnings - MarketBeat
Connect Biopharma asthma, COPD trials to continue as planned By Investing.com - Investing.com India
CNTB SEC FilingsConnect Biopharma Holdings Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Connect Biopharma asthma, COPD trials to continue as planned - Investing.com
Connect Biopharma Continues Phase 2 Seabreeze STAT Trials for Rademikibart in Asthma and COPD with Topline Data Expected Mid-2026 - Minichart
Connect Biopharma: DMC clears interim analysis; Phase 2 Seabreeze STAT enrollment to continue - TradingView
Connect Biopharma (NASDAQ: CNTB) DMC backs Seabreeze STAT trials, topline data mid-2026 - Stock Titan
Interim review leaves asthma, COPD drug studies unchanged ahead of mid-2026 data - Stock Titan
Connect Bio (CNTB) Stock: Market Efficiency (At Highs) 2026-04-20Trending Picks - Cổng thông tin điện tử tỉnh Lào Cai
CNTB | Connect Biopharma Holdings Limited Insider Trading - Quiver Quantitative
Connect Biopharma Holdings (CNTB) insider-linked stake of 9.6% disclosed - Stock Titan
Q1 Earnings Estimate for CNTB Issued By HC Wainwright - MarketBeat
Is Connect Bio (CNTB) Stock Consolidating | Price at $2.69, Up 2.28%Expert Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La
H.C. Wainwright Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Director at Connect Biopharma (CNTB) takes shares instead of cash pay - Stock Titan
[Form 4] Connect Biopharma Holdings Ltd Insider Trading Activity - Stock Titan
Connect Biopharma (NASDAQ:CNTB) Director James Huang Acquires 1,160,000 Shares - MarketBeat
Entity tied to CNTB director James Huang buys 1.16M shares in open market - Stock Titan
Connect Biopharma (NASDAQ: CNTB) holder Panacea adds 1.16M shares - Stock Titan
Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
ETFs Investing in Connect Biopharma Holdings Ltd. Stocks - TradingView — Track All Markets
Connect Biopharma Holdings Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update - The Manila Times
Rademikibart drives Connect Biopharma (NASDAQ: CNTB) asthma and COPD strategy - Stock Titan
[8-K] Connect Biopharma Holdings Ltd Reports Material Event - Stock Titan
코넥트 바이오파마 (CNTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.49%
0.12%
자본화:
|
볼륨(24시간):